Tepilta® Versus Oxetacaine, Antacids and Placebo

This study has been terminated.

(The study stopped prematurely due to and administrative reasons, not based on grounds of safety.)

Sponsor:

Collaborators:

Trium Analysis Online GmbH

ICON plc

Clinipace Worldwide

Information provided by (Responsible Party):

MEDA Pharma GmbH & Co. KG

ClinicalTrials.gov Identifier:

NCT01336530

First received: April 1, 2011

Last updated: May 18, 2017

Last verified: February 2017

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Study Completion Date:	January 2017
Primary Completion Date:	January 2017 (Final data collection date for primary outcome measure)